difference between tirzepatide vs semaglutide vs. Semaglutide: What You Should Know We know about the growing

Patients with diabetes who received semaglutide had a higher long-term risk of nonarteritic anterior ischemic optic neuropathy compared with matched patients who received nonglucagon-like peptide-1 receptor agonist antidiabetic medications, according to a retrospective cohort study published in JAMA Ophthalmology

One of the most promising drug classes in recent years is GLP-1 receptor agonists, including semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro).These medications have revolutionized weight loss and diabetes management, with additional potential benefits in reducing risks for conditions like sleep apnea, cardiovascular disease, and even alcohol dependence

This drug resistance can be triggered by the genomic instability that leads to tumor heterogeneity, involved in cancer progression

PTEN induced putative kinase 1 (PINK1) alleviates angiotensin II-induced cardiac injury by ameliorating mitochondrial dysfunction